119 related articles for article (PubMed ID: 29046806)
1. Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer.
Nakagawa M; Karashima T; Kamada M; Yoshida E; Yoshimura T; Nojima M; Inoue K; Shuin T; Seiki M; Koshikawa N
Biomark Res; 2017; 5():29. PubMed ID: 29046806
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of urine laminin-γ2 monomer as a potent biomarker for non-muscle invasive bladder cancer.
Karashima T; Umemoto S; Kishida T; Osaka K; Nakagawa M; Yoshida E; Yoshimura T; Sakaguchi M; Nishimoto H; Tai M; Inoue K; Seiki M; Koshikawa N; Shuin T
Cancer Med; 2023 Feb; 12(3):2453-2462. PubMed ID: 35924681
[TBL] [Abstract][Full Text] [Related]
3. Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review.
Yasuda H; Nakagawa M; Kiyokawa H; Yoshida E; Yoshimura T; Koshikawa N; Itoh F; Seiki M
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626121
[TBL] [Abstract][Full Text] [Related]
4. Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma.
Kamada M; Koshikawa N; Minegishi T; Kawada C; Karashima T; Shuin T; Seiki M
Cancer Sci; 2015 Dec; 106(12):1730-7. PubMed ID: 26450632
[TBL] [Abstract][Full Text] [Related]
5. Expression of laminin gamma2 chain monomer enhances invasive growth of human carcinoma cells in vivo.
Tsubota Y; Ogawa T; Oyanagi J; Nagashima Y; Miyazaki K
Int J Cancer; 2010 Nov; 127(9):2031-41. PubMed ID: 20143393
[TBL] [Abstract][Full Text] [Related]
6. Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer.
Chang Y; Xu J; Zhang Q
Oncol Lett; 2017 Oct; 14(4):4043-4052. PubMed ID: 28943911
[TBL] [Abstract][Full Text] [Related]
7. Laminin-5 immunocytochemistry: a new tool for identifying dysplastic cells in oral brush biopsies.
Driemel O; Dahse R; Hakim SG; Tsioutsias T; Pistner H; Reichert TE; Kosmehl H
Cytopathology; 2007 Dec; 18(6):348-55. PubMed ID: 18031447
[TBL] [Abstract][Full Text] [Related]
8. Laminin gamma2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion.
Katayama M; Sanzen N; Funakoshi A; Sekiguchi K
Cancer Res; 2003 Jan; 63(1):222-9. PubMed ID: 12517801
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical distribution of laminin-5 gamma2 chain and its developmental change in human embryonic and foetal tissues.
Lu W; Miyazaki K; Mizushima H; Nemoto N
Histochem J; 2001; 33(11-12):629-37. PubMed ID: 12197671
[TBL] [Abstract][Full Text] [Related]
10. Development of a new tracking tool for the human monomeric laminin-gamma 2 chain in vitro and in vivo.
Koshikawa N; Minegishi T; Nabeshima K; Seiki M
Cancer Res; 2008 Jan; 68(2):530-6. PubMed ID: 18199549
[TBL] [Abstract][Full Text] [Related]
11. Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
Zhang X; Zhang Y; Liu X; Fang A; Wang J; Yang Y; Wang L; Du L; Wang C
Oncotarget; 2016 Jan; 7(3):3255-66. PubMed ID: 26657502
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of LAMC2 predicts poor prognosis in colorectal cancer patients and promotes cancer cell proliferation, migration, and invasion.
Huang D; Du C; Ji D; Xi J; Gu J
Tumour Biol; 2017 Jun; 39(6):1010428317705849. PubMed ID: 28653882
[TBL] [Abstract][Full Text] [Related]
13. Effect of laminin 332 on motility and invasion in bladder cancer.
Kang SG; Ha YR; Ko YH; Kang SH; Joo KJ; Cho HY; Park HS; Kim CH; Kwon SY; Kim JJ; Cheon J; Lee JG
Kaohsiung J Med Sci; 2013 Aug; 29(8):422-9. PubMed ID: 23906232
[TBL] [Abstract][Full Text] [Related]
14. Highly specific urine-based marker of bladder cancer.
Van Le TS; Miller R; Barder T; Babjuk M; Potter DM; Getzenberg RH
Urology; 2005 Dec; 66(6):1256-60. PubMed ID: 16360453
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer.
Teng Y; Wang Z; Ma L; Zhang L; Guo Y; Gu M; Wang Z; Wang Y; Yue W
Onco Targets Ther; 2016; 9():4151-62. PubMed ID: 27462170
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
Ii M; Yamamoto H; Taniguchi H; Adachi Y; Nakazawa M; Ohashi H; Tanuma T; Sukawa Y; Suzuki H; Sasaki S; Imai K; Shinomura Y
Int J Oncol; 2011 Sep; 39(3):593-9. PubMed ID: 21617852
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid laminin-5 gamma2 chain levels in chronic periodontitis.
Emingil G; Atilla G; Sorsa T; Savolainen P; Baylas H
J Periodontol; 2004 Oct; 75(10):1387-96. PubMed ID: 15562917
[TBL] [Abstract][Full Text] [Related]
18. Laminin gamma2 chain as a stromal cell marker of the human bone marrow microenvironment.
Siler U; Rousselle P; Müller CA; Klein G
Br J Haematol; 2002 Oct; 119(1):212-20. PubMed ID: 12358928
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathologic significance of laminin-5 gamma2 chain expression in cervical squamous carcinoma and adenocarcinoma.
Andersson S; Hellström AC; Angström T; Stendahl U; Auer G; Wallin KL
Int J Gynecol Cancer; 2005; 15(6):1065-72. PubMed ID: 16343183
[TBL] [Abstract][Full Text] [Related]
20. Gingival crevicular fluid laminin-5 gamma2-chain levels in periodontal disease.
Emingil G; Kuula H; Pirilä E; Atilla G; Sorsa T
J Clin Periodontol; 2006 Jul; 33(7):462-8. PubMed ID: 16820033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
